# Radiant Logistics, Inc: financial statements, quarterly

RLGT · NYSE · CIK 1171155 · [Industrials](/sectors/industrials.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/rlgt.md) · [Financials](/companies/rlgt/financials.md) · [Filings](/companies/rlgt/filings.md) · [Insiders](/companies/rlgt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rlgt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [211](/filings/0000950170-24-125601.md) | [201](/filings/0000950170-25-017143.md) | [185](/filings/0000950170-25-069416.md) | [206 d](/filings/0001193125-25-203690.md) | [204](/filings/0001193125-25-274478.md) | [265](/filings/0001193125-26-042887.md) | [214](/filings/0001193125-26-216902.md) | [221 d](/filings/0001193125-26-390768.md) | [227](/filings/0001193125-25-274478.md) | [232](/filings/0001193125-26-042887.md) | [214](/filings/0001193125-26-216902.md) | [261 d](/filings/0001193125-26-390768.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [9.5](/filings/0000950170-24-125601.md) | [10.5](/filings/0000950170-25-017143.md) | [10.0](/filings/0000950170-25-069416.md) | [8.7 d](/filings/0001193125-25-203690.md) | [10.3](/filings/0001193125-25-274478.md) | [12.0](/filings/0001193125-26-042887.md) | [9.9](/filings/0001193125-26-216902.md) | [10.2 d](/filings/0001193125-26-390768.md) | [12.1](/filings/0001193125-25-274478.md) | [9.6](/filings/0001193125-26-042887.md) | [9.3](/filings/0001193125-26-216902.md) | [11.4 d](/filings/0001193125-26-390768.md) |
| Operating income | $m | [3.7](/filings/0000950170-24-125601.md) | [1.7](/filings/0000950170-25-017143.md) | [(0.9)](/filings/0000950170-25-069416.md) | [4.9 d](/filings/0001193125-25-203690.md) | [3.8](/filings/0001193125-25-274478.md) | [8.7](/filings/0001193125-26-042887.md) | [3.3](/filings/0001193125-26-216902.md) | [5.2 d](/filings/0001193125-26-390768.md) | [2.1](/filings/0001193125-25-274478.md) | [7.5](/filings/0001193125-26-042887.md) | [6.5](/filings/0001193125-26-216902.md) | [8.5 d](/filings/0001193125-26-390768.md) |
| Interest expense | $m | [0.3](/filings/0000950170-23-062195.md) | [0.3](/filings/0000950170-24-012870.md) | [0.3](/filings/0000950170-24-057224.md) | [0.2 d](/filings/0000950170-24-105991.md) | [0.2](/filings/0001193125-25-274478.md) | [0.3](/filings/0001193125-26-042887.md) | [0.3](/filings/0001193125-26-216902.md) | [0.5 d](/filings/0001193125-26-390768.md) | [0.6](/filings/0001193125-25-274478.md) | [0.6](/filings/0001193125-26-042887.md) | [0.6](/filings/0001193125-26-216902.md) | [0.5 d](/filings/0001193125-26-390768.md) |
| Income tax | $m | [1.0](/filings/0000950170-24-125601.md) | [0.4](/filings/0000950170-25-017143.md) | [0.0](/filings/0000950170-25-069416.md) | [0.1 d](/filings/0001193125-25-203690.md) | [1.1](/filings/0001193125-25-274478.md) | [2.2](/filings/0001193125-26-042887.md) | [0.6](/filings/0001193125-26-216902.md) | [(0.1) d](/filings/0001193125-26-390768.md) | [0.3](/filings/0001193125-25-274478.md) | [1.7](/filings/0001193125-26-042887.md) | [1.9](/filings/0001193125-26-216902.md) | [0.3 d](/filings/0001193125-26-390768.md) |
| Net income | $m | [2.6](/filings/0000950170-24-125601.md) | [1.0](/filings/0000950170-25-017143.md) | [(0.7)](/filings/0000950170-25-069416.md) | [4.8 d](/filings/0001193125-25-203690.md) | [3.4](/filings/0001193125-25-274478.md) | [6.5](/filings/0001193125-26-042887.md) | [2.5](/filings/0001193125-26-216902.md) | [4.9 d](/filings/0001193125-26-390768.md) | [1.3](/filings/0001193125-25-274478.md) | [5.3](/filings/0001193125-26-042887.md) | [4.7](/filings/0001193125-26-216902.md) | [7.5 d](/filings/0001193125-26-390768.md) |
| Diluted EPS | $ per share | [0.05](/filings/0000950170-24-125601.md) | [0.02](/filings/0000950170-25-017143.md) | [(0.02)](/filings/0000950170-25-069416.md) | not reported | [0.07](/filings/0001193125-25-274478.md) | [0.13](/filings/0001193125-26-042887.md) | [0.05](/filings/0001193125-26-216902.md) | not reported | [0.03](/filings/0001193125-25-274478.md) | [0.11](/filings/0001193125-26-042887.md) | [0.10](/filings/0001193125-26-216902.md) | not reported |
| Basic EPS | $ per share | [0.06](/filings/0000950170-24-125601.md) | [0.02](/filings/0000950170-25-017143.md) | [(0.02)](/filings/0000950170-25-069416.md) | not reported | [0.07](/filings/0001193125-25-274478.md) | [0.14](/filings/0001193125-26-042887.md) | [0.05](/filings/0001193125-26-216902.md) | not reported | [0.03](/filings/0001193125-25-274478.md) | [0.11](/filings/0001193125-26-042887.md) | [0.10](/filings/0001193125-26-216902.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Gross profit: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [35.9](/filings/0000950170-24-125601.md) | [32.9](/filings/0000950170-25-017143.md) | [31.2](/filings/0000950170-25-069416.md) | [24.9](/filings/0001193125-25-203690.md) | [10.4](/filings/0000950170-24-125601.md) | [19.9](/filings/0000950170-25-017143.md) | [19.0](/filings/0000950170-25-069416.md) | [22.9](/filings/0001193125-26-390768.md) | [28.1](/filings/0001193125-25-274478.md) | [31.9](/filings/0001193125-26-042887.md) | [39.7](/filings/0001193125-26-216902.md) | [25.6](/filings/0001193125-26-390768.md) |
| Current assets | $m | [172](/filings/0000950170-23-062195.md) | [161](/filings/0000950170-24-012870.md) | [160](/filings/0000950170-24-057224.md) | [164](/filings/0001193125-25-203690.md) | [158](/filings/0000950170-24-125601.md) | [153](/filings/0000950170-25-017143.md) | [170](/filings/0000950170-25-069416.md) | [179](/filings/0001193125-26-390768.md) | [195](/filings/0001193125-25-274478.md) | [191](/filings/0001193125-26-042887.md) | [189](/filings/0001193125-26-216902.md) | [208](/filings/0001193125-26-390768.md) |
| Total assets | $m | [378](/filings/0000950170-24-125601.md) | [363](/filings/0000950170-25-017143.md) | [364](/filings/0000950170-25-069416.md) | [371](/filings/0001193125-25-203690.md) | [375](/filings/0000950170-24-125601.md) | [387](/filings/0000950170-25-017143.md) | [415](/filings/0000950170-25-069416.md) | [427](/filings/0001193125-26-390768.md) | [445](/filings/0001193125-25-274478.md) | [439](/filings/0001193125-26-042887.md) | [431](/filings/0001193125-26-216902.md) | [444](/filings/0001193125-26-390768.md) |
| Current liabilities | $m | [118](/filings/0000950170-23-062195.md) | [108](/filings/0000950170-24-012870.md) | [106](/filings/0000950170-24-057224.md) | [110](/filings/0001193125-25-203690.md) | [109](/filings/0000950170-24-125601.md) | [108](/filings/0000950170-25-017143.md) | [114](/filings/0000950170-25-069416.md) | [115](/filings/0001193125-26-390768.md) | [121](/filings/0001193125-25-274478.md) | [120](/filings/0001193125-26-042887.md) | [119](/filings/0001193125-26-216902.md) | [130](/filings/0001193125-26-390768.md) |
| Total liabilities | $m | [171](/filings/0000950170-23-062195.md) | [156](/filings/0000950170-24-012870.md) | [158](/filings/0000950170-24-057224.md) | [162](/filings/0001193125-25-203690.md) | [163](/filings/0000950170-24-125601.md) | [172](/filings/0000950170-25-017143.md) | [196](/filings/0000950170-25-069416.md) | [201](/filings/0001193125-26-390768.md) | [218](/filings/0001193125-25-274478.md) | [208](/filings/0001193125-26-042887.md) | [196](/filings/0001193125-26-216902.md) | [201](/filings/0001193125-26-390768.md) |
| Long-term debt | $m | [0.0](/filings/0000950170-23-062195.md) | [0.0](/filings/0000950170-24-012870.md) | [0.0](/filings/0000950170-24-057224.md) | [0.0](/filings/0000950170-24-105991.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | [2.9](/filings/0000950170-23-062195.md) | [1.8](/filings/0000950170-24-012870.md) | [0.6](/filings/0000950170-24-057224.md) | [0.0](/filings/0000950170-24-105991.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [207](/filings/0000950170-23-062195.md) | [207](/filings/0000950170-24-012870.md) | [206](/filings/0000950170-24-057224.md) | [209](/filings/0001193125-25-203690.md) | [212](/filings/0000950170-24-125601.md) | [214](/filings/0000950170-25-017143.md) | [218](/filings/0000950170-25-069416.md) | [226](/filings/0001193125-26-390768.md) | [226](/filings/0001193125-25-274478.md) | [230](/filings/0001193125-26-042887.md) | [234](/filings/0001193125-26-216902.md) | [242](/filings/0001193125-26-390768.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [7.9](/filings/0000950170-24-125601.md) | [4.2 d](/filings/0000950170-25-017143.md) | [3.9 d](/filings/0000950170-25-069416.md) | [1.3 d](/filings/0001193125-25-203690.md) | [0.2](/filings/0001193125-25-274478.md) | [15.7 d](/filings/0001193125-26-042887.md) | [(5.7) d](/filings/0001193125-26-216902.md) | [3.1 d](/filings/0001193125-26-390768.md) | [2.5](/filings/0001193125-25-274478.md) | [12.4 d](/filings/0001193125-26-042887.md) | [14.6 d](/filings/0001193125-26-216902.md) | [(11.9) d](/filings/0001193125-26-390768.md) |
| Capital expenditure | $m | [2.5](/filings/0000950170-24-125601.md) | [2.5 d](/filings/0000950170-25-017143.md) | [2.1 d](/filings/0000950170-25-069416.md) | [1.4 d](/filings/0001193125-25-203690.md) | [2.1](/filings/0001193125-25-274478.md) | [1.5 d](/filings/0001193125-26-042887.md) | [0.6 d](/filings/0001193125-26-216902.md) | [0.9 d](/filings/0001193125-26-390768.md) | [1.5](/filings/0001193125-25-274478.md) | [0.7 d](/filings/0001193125-26-042887.md) | [1.3 d](/filings/0001193125-26-216902.md) | [0.8 d](/filings/0001193125-26-390768.md) |
| Share repurchases | $m | [0.2](/filings/0000950170-24-125601.md) | [2.9 d](/filings/0000950170-25-017143.md) | [0.0 d](/filings/0000950170-25-069416.md) | [1.0 d](/filings/0001193125-25-203690.md) | [0.7](/filings/0001193125-25-274478.md) | [0.0 d](/filings/0001193125-26-042887.md) | [0.0 d](/filings/0001193125-26-216902.md) | [0.1 d](/filings/0001193125-26-390768.md) | [0.8](/filings/0001193125-25-274478.md) | [2.7 d](/filings/0001193125-26-042887.md) | [0.0 d](/filings/0001193125-26-216902.md) | [0.0 d](/filings/0001193125-26-390768.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [50.3](/filings/0000950170-23-062195.md) | [49.4](/filings/0000950170-24-012870.md) | [49.3](/filings/0000950170-24-057224.md) | [49.1](/filings/0000950170-24-125601.md) | [48.9](/filings/0000950170-25-017143.md) | [47.0](/filings/0000950170-25-069416.md) | [48.6](/filings/0001193125-25-274478.md) | [49.0](/filings/0001193125-26-042887.md) | [48.7](/filings/0001193125-26-216902.md) | [48.7](/filings/0001193125-25-274478.md) | [48.7](/filings/0001193125-26-042887.md) | [48.5](/filings/0001193125-26-216902.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 46,894,270 at 2026-09-08, from the cover of the [10-K filed 2026-09-14](/filings/0001193125-26-390768.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.